Medistep Healthcare Limited (NSE:MEDISTEP)
India · Delayed Price · Currency is INR 22.50
0.00 (0.00%)
At close: Sep 11, 2026
Medistep Healthcare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 6.13 | 13.1 | 0.1 | 1.24 | 0.31 |
Cash & Short-Term Investments | 6.13 | 13.1 | 0.1 | 1.24 | 0.31 |
Cash Growth | -53.21% | 13406.19% | -92.20% | 300.97% | - |
Accounts Receivable | 393.86 | 201.15 | 137.51 | 139.83 | 57.26 |
Other Receivables | - | - | 0.99 | 0.16 | 0.28 |
Receivables | 393.86 | 201.15 | 138.5 | 139.99 | 61.65 |
Inventory | 61.82 | 10.95 | 9.29 | 5.05 | 4.03 |
Prepaid Expenses | 0.7 | 2.41 | - | - | - |
Other Current Assets | 39.09 | 0.85 | - | - | 0.07 |
Total Current Assets | 501.6 | 228.46 | 147.88 | 146.27 | 66.05 |
Property, Plant & Equipment | 1.22 | 1.4 | 1.55 | 0.25 | 4.9 |
Long-Term Investments | - | 0.02 | 0.02 | 0.02 | 0.02 |
Long-Term Deferred Tax Assets | 0.09 | 0.07 | 0.06 | 0.04 | 0.01 |
Other Long-Term Assets | 0.07 | 0.07 | 0.06 | - | - |
Total Assets | 502.97 | 230.01 | 149.56 | 146.57 | 70.97 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 36.5 | 24.53 | 14.1 | 126.41 | 54.12 |
Accrued Expenses | 1.6 | 1.41 | 0.25 | 0.19 | 0.81 |
Short-Term Debt | 51.81 | 6.35 | 0.49 | 0.51 | 0.5 |
Current Portion of Long-Term Debt | - | - | 2.05 | 2.21 | 1.85 |
Current Income Taxes Payable | 34.02 | 23.8 | 14.99 | 3.77 | 0.64 |
Other Current Liabilities | 0.54 | 0.18 | - | 0.16 | 1.51 |
Total Current Liabilities | 124.48 | 56.26 | 31.87 | 133.24 | 59.43 |
Long-Term Debt | - | - | 0.72 | 2.61 | 8.23 |
Pension & Post-Retirement Benefits | 0.25 | 0.22 | 0.07 | - | - |
Other Long-Term Liabilities | - | - | - | 0 | - |
Total Liabilities | 124.73 | 56.49 | 32.66 | 135.85 | 67.66 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 142.1 | 104.66 | 48.99 | 10.72 | 3.31 |
Additional Paid-In Capital | 126.89 | 3.33 | 44.09 | - | - |
Retained Earnings | 109.27 | 65.53 | 23.82 | - | - |
Comprehensive Income & Other | - | 0 | - | - | - |
Shareholders' Equity | 378.25 | 173.52 | 116.91 | 10.72 | 3.31 |
Total Liabilities & Equity | 502.97 | 230.01 | 149.56 | 146.57 | 70.97 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 51.81 | 6.35 | 3.26 | 5.32 | 10.57 |
Net Cash (Debt) | -45.68 | 6.75 | -3.16 | -4.08 | -10.26 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -3.57 | 0.65 | -2.17 | - | - |
Filing Date Shares Outstanding | 14.21 | 14.21 | 4.9 | - | - |
Total Common Shares Outstanding | 14.21 | 10.47 | 4.9 | - | - |
Working Capital | 377.12 | 172.2 | 116.01 | 13.04 | 6.63 |
Book Value Per Share | 26.62 | 16.58 | 23.86 | - | - |
Tangible Book Value | 378.25 | 173.52 | 116.91 | 10.72 | 3.31 |
Tangible Book Value Per Share | 26.62 | 16.58 | 23.86 | - | - |
Buildings | - | - | - | - | 4.27 |
Machinery | 2.03 | 1.94 | 2.03 | 0.51 | 1.24 |